Penn Medicine's new Colton Center for Autoimmunity unites the university's immunology research and patient care programs, joining NYU and Yale in a shared effort to advance autoimmune disease diagnosis and treatment.
A $50 million gift from Stewart and Judy Colton will elevate Penn Medicine's Colton Center for Autoimmunity into a global leader in autoimmune research, treatment, and cross-institutional collaboration.
NYU Langone's Colton-backed Division of Rheumatology is taking a leading role in the NIH's $58 million AMP AIM program, driving research into lupus, psoriatic disease, Sjögren's disease, and the microbiome.
Yale immunologist Dr. Joseph Craft outlines the mission of the newly launched Colton Center for Autoimmunity — a cross-disciplinary initiative to translate autoimmune research into real-world diagnostics and treatments.
NYU Langone's Colton Center has funded seven new autoimmune pilot projects for 2019 — targeting myasthenia gravis, rheumatoid arthritis, and lupus — while earlier grants advance toward clinical diagnostics and therapies.
NYU Langone's Colton Center for Autoimmunity profiles its cross-disciplinary pilot research program — connecting researchers across rheumatology, immunology, genetics, and neuroimmunology to accelerate autoimmune disease breakthroughs.
